Vilin Bio Med
add_icon

Vilin Bio Med

47.70
0.00
(0.00%)
Market Cap
72.74 Cr
PE Ratio
37.86
Volume
0.00
Day High - Low
- - -
52W High-Low
54.40 - 18.95
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
72.74 Cr
EPS
1.37
PE Ratio
37.86
PB Ratio
2.56
Book Value
18.60
EBITDA
3.19
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
0.97
Debt to Equity
0.20
Forecast For
Actual

Company News

View All News
Caret
neutral
Vilin Bio Med Limited reclassified outgoing promoter to public category following open offer completion. Mr. Devireddy Srinivas Reddy now holds 3.19% stake.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,788.50
#1 4,29,121.06
37.31
#1 58,220.10
6.38
#1 11,565
25.80
44.37
6,576.50
1,74,585.41
67.49
10,560.00
8.73
2,520
13.44
46.75
4,368.50
1,47,849.89
68.30
13,753.00
19.18
2,028
-26.91
50.11
1,375.20
1,11,086.00
28.84
27,711.70
-2.46
3,783
-55.32
52.65
1,076.60
1,08,331.15
21.16
26,719.70
13.65
5,242
7.82
68.91
1,263.30
1,05,440.45
25.59
33,593.30
-0.44
3,998
-86.05
41.47
2,261.20
1,03,346.61
#1 19.21
27,487.50
19.98
5,345
#1 87.72
45.17
2,369.50
97,814.16
48.97
14,277.60
12.03
1,750
31.75
50.42
1,440.40
83,658.67
23.70
33,384.70
3.21
3,376
1.99
48.90
1,394.30
75,272.20
83.88
6,812.90
#1 21.03
884
21.18
76.00
Growth Rate
Revenue Growth
176.21 %
Net Income Growth
880.00 %
Cash Flow Change
102.96 %
ROE
36.62 %
ROCE
13.73 %
EBITDA Margin (Avg.)
-8.15 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
17
12
11
12
16
15
42
8
Expenses
16
11
10
10
15
14
39
7
EBITDA
1
1
1
3
1
1
3
2
Operating Profit %
5 %
7 %
7 %
21 %
5 %
5 %
8 %
8 %
Depreciation
0
0
0
0
0
0
0
0
Interest
0
0
1
1
1
1
0
0
Profit Before Tax
0
0
0
2
0
0
3
1
Tax
0
0
0
1
0
0
1
0
Net Profit
0
0
0
1
0
0
2
1
EPS in ₹
0.20
0.15
0.10
1.25
0.12
0.16
1.37
2.20

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
14
14
14
18
32
28
35
Fixed Assets
2
2
2
2
1
1
3
Current Assets
12
12
12
8
19
13
27
Capital Work in Progress
0
0
0
0
0
2
0
Investments
0
0
0
0
0
0
7
Other Assets
12
12
12
16
31
25
0
Total Equity & Liabilities
14
14
14
18
32
28
35
Current Liabilities
7
6
5
7
9
5
6
Non Current Liabilities
0
1
1
1
0
0
0
Total Equity
7
7
7
11
23
23
28
Reserve & Surplus
4
4
4
1
9
9
13
Share Capital
3
3
3
10
14
14
15

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
2
-6
Investing Activities
0
0
0
0
0
-1
Operating Activities
-2
-1
0
-2
-7
0
Financing Activities
2
1
-0
2
9
-5

Share Holding

% Holding
Jun 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
90.45 %
64.52 %
64.52 %
64.09 %
63.89 %
63.89 %
63.89 %
63.65 %
59.57 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.45 %
32.80 %
33.84 %
34.47 %
34.18 %
33.49 %
33.55 %
33.95 %
30.19 %
Others
0.10 %
2.68 %
1.65 %
1.45 %
1.94 %
2.62 %
2.57 %
2.39 %
10.24 %
No of Share Holders
827
659
585
581
551
492
476
462
421

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 18.85 18.05
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 24.40 22.90
17 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 May 2025 25.35 26.55
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 26.50 24.95
09 Feb 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
09 Feb 2026 26.50 36.00
30 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2026 48.50 46.55

Technical Indicators

RSI(14)
Neutral
66.01
ATR(14)
Less Volatile
1.34
STOCH(9,6)
Neutral
37.43
STOCH RSI(14)
Oversold
18.98
MACD(12,26)
Bearish
0.00
ADX(14)
Strong Trend
42.01
UO(9)
Bearish
39.16
ROC(12)
Uptrend And Accelerating
17.06
WillR(14)
Neutral
-39.30